Tech Company Financing Transactions

Passkey Therapeutics Funding Round

On 10/22/2024, Passkey Therapeutics secured $20 million in Seed funding from Breakout Ventures, Alexandria Venture Investments and Bison Ventures.

Transaction Overview

Announced On
10/22/2024
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to support its development of SMThs (pronounced "smiths"), a new class of single-drug therapies designed to modulate rare combinations of proteins that work together, and Locksmith, its proprietary computational and experimental platform for SMTh discovery.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
One Kendall Square, Building 200 001
Cambridge, MA 02139
USA
Phone
Undisclosed
Email Address
Overview
We are biotech and pharma veterans with diverse backgrounds in computational and experimental drug discovery and a shared dedication to improving the lives of patients with complex diseases.
Profile
Passkey Therapeutics LinkedIn Company Profile
Social Media
Passkey Therapeutics Company Twitter Account
Company News
Passkey Therapeutics News
Facebook
Passkey Therapeutics on Facebook
YouTube
Passkey Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Bruce Beutel
  Bruce Beutel LinkedIn Profile  Bruce Beutel Twitter Account  Bruce Beutel News  Bruce Beutel on Facebook
Chief Operating Officer
Peter Dandliker
  Peter Dandliker LinkedIn Profile  Peter Dandliker Twitter Account  Peter Dandliker News  Peter Dandliker on Facebook
Chief Technical Officer
Will Chen
  Will Chen LinkedIn Profile  Will Chen Twitter Account  Will Chen News  Will Chen on Facebook
Co-Founder
Soumya Ray
  Soumya Ray LinkedIn Profile  Soumya Ray Twitter Account  Soumya Ray News  Soumya Ray on Facebook
Vice President
Robert Gentles
  Robert Gentles LinkedIn Profile  Robert Gentles Twitter Account  Robert Gentles News  Robert Gentles on Facebook
VP - Finance
Joel Yeshman
  Joel Yeshman LinkedIn Profile  Joel Yeshman Twitter Account  Joel Yeshman News  Joel Yeshman on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/22/2024: Universal Fuel Technologies venture capital transaction
Next: 10/22/2024: Vortexa venture capital transaction

 

Share this article

 


News on VC Transactions

We report on all VC transactions involving tech companies. All VC database entries reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary